Zepbound Tracker App — Track Your Weight Loss Journey

Zepbound (tirzepatide) is an FDA-approved medication specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition. It contains the same active ingredient as Mounjaro but is indicated for weight loss rather than diabetes management.

Zepbound is a first-in-class dual GLP-1 and GIP receptor agonist, administered as a once-weekly subcutaneous injection. It's available in six dosage strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. The standard titration starts at 2.5mg and increases by 2.5mg every 4 weeks to minimize side effects while optimizing weight loss results.

The medication has a half-life of approximately 5 days, enabling once-weekly dosing with relatively stable medication levels. In clinical trials (SURMOUNT studies), Zepbound demonstrated an average weight loss of 20-22% of body weight over 72 weeks at the 15mg dose, making it one of the most effective weight loss medications available.

Unlike GLP-1-only agonists (semaglutide), tirzepatide's dual action on both GLP-1 and GIP receptors may provide enhanced appetite suppression, improved insulin sensitivity, and greater weight loss for many patients. The GIP component is thought to complement GLP-1's effects on satiety and metabolism.

This is not medical advice. Zepbound should only be taken under the supervision of a qualified healthcare provider. Consult your doctor for dosage instructions and medical guidance.

Weight management with Zepbound is a long-term commitment that works best when combined with lifestyle changes and consistent tracking. Understanding how your body responds to medication throughout the week helps you optimize meal timing, manage expectations, and stay motivated during plateaus.

Many Zepbound users report that appetite suppression fluctuates throughout their weekly dosing cycle. Some feel the strongest effects 2-3 days after injection, while others maintain more consistent suppression. By visualizing medication levels alongside hunger and food noise ratings, you can identify your personal pattern and plan accordingly.

The extended titration schedule means you'll be adjusting doses every 4 weeks for potentially 20-24 weeks. Detailed tracking helps you and your doctor determine whether you're ready for the next increase or if you should stay at your current dose longer to manage side effects or maximize weight loss at that level.

Weight loss isn't always linear - you'll experience weeks with significant drops and weeks with plateaus. Tracking medication levels, injection compliance, side effects, and weight trends helps you understand these fluctuations and maintain perspective during challenging weeks.

Finally, comprehensive tracking creates valuable data for follow-up appointments. Instead of vague discussions about "how it's going," you can show your doctor specific patterns: "I experienced moderate nausea for 2 days after each dose increase, then it resolved," or "My weight loss stalled at 10mg, but appetite suppression remained strong."

1. Download JellyPal from the App Store or Google Play Store. The app is free to download with core tracking features available at no cost.
2. Select Zepbound as your medication and choose your current dosage (typically starting at 2.5mg).
3. Log your first injection including the date, time, and injection site. JellyPal will start tracking your medication levels immediately.
4. Track daily metrics by spending 10-30 seconds each day logging your weight (weekly is fine), rating hunger and food noise, and noting any side effects. This data becomes incredibly valuable over time.
5. Review your insights by checking the PK plotter to see medication levels, reviewing weight loss trends, and preparing data-driven questions for your next doctor visit.